Vaccination by election against COVID-19 by the mexican community
DOI:
https://doi.org/10.19230/jonnpr.4140Keywords:
Covid-19 vaccine, global health, pandemic, impact, covid-19Abstract
The COVID-19 pandemic is the defining global health crisis of our time, it is the greatest challenge that has been faced in a long time. This is why health organizations work hard to find a vaccine that reduces the impact of this virus.
Objective. Describe the opinion of the public about the COVID-19 vaccine to generate an overview of the community's knowledge, the impact it will have, as well as the preventive health areas that will support the community to be convinced of applying the vaccine.
Method. A descriptive, cross-sectional observational study was carried out by applying a survey in Google forms to men and women from the states of Hidalgo, Guerrero, Puebla and Mexico to 150 people with an age range of 15-80 years.
Results. 29.33% would not apply the vaccine against COVID-19 mainly due to fear of adverse consequences and lack of knowledge, on the other hand 70.67% indicated that they would apply it because they trust the advances of science in the area Of the health.
Conclusion. It is necessary to implement more knowledge in the Mexican population to generate interest in health advances, as is the vaccine for covid-19, otherwise the results will be negative.
Downloads
References
OPS. La OMS caracteriza a COVID-19 como una pandemia. [Internet]. Ginebra. 11 de marzo de 2020. [Consultado 11 de octubre 2020]. Disponible en: https://www.paho.org/es/noticias/11-3-2020-oms-caracteriza-covid-19-como- pandemia
UNDP. Enfermedad por Coronavirus (COVID-19): La Pandemia [Internet]. s.f. [Consultado 8 de octubre 2020] Disponible at: https://www.undp.org/content/undp/es/home/coronavirus.html
Bish. Demographic and attitudinal determinants of protective behaviours during a pandemic: A review. BJHP [Internet] 2010 [Consultado 22 octubre 2020] 15: https://doi.org/10.1348/135910710X485826. Disponible en: https://bpspsychub.onlinelibrary.wiley.com/doi/full/10.1348/135910710X485826
T. Thanh Le, Z. Andreadakis, A. Kumar, et al. The COVID-19 vaccine development landscape Nat Rev Drug Discov. [Internet] 2020 [Consultado 22 octubre 2020] 19 (5), pp. 305-306. Disponible en: https://www.researchgate.net/profile/Tung_Le53/publication/340535627_The_COVID-19_vaccine_development_landscape/links/5ead65c5a6fdcc7050a1c089/The-COVID-19-vaccine-development-landscape.pdf
Lanese N. ¿Cuándo estará lista una vacuna COVID-19? 2020. [Internet] [Consultado 22 octubre 2020] Disponible en: https://www.livescience.com/coronavirus-covid-19-vaccine-timeline.html
Santos J. La vacunación en México en el marco de las “décadas de las vacunas”: logros y desafíos. [Internet]. Medigraphic.com. 2020. [Consultado 5 Octubre 2020]. Disponible en: https://www.medigraphic.com/pdfs/gaceta/gm-2014/gm142k.pdf
Manual de Vacunación 2008-2009. México, D.F. 2008[Internet].[ consultado el 22 de octubre de 2020 ]https://drive.google.com/file/d/1N5W693FsKIAZKu6iqbVxgdiIoXlhUYdW/view?usp=drivesdk
Cortés M. Coronavirus como amenaza a la salud pública [Internet]. SciElo. 2020. [Consultado 5 Octubre 2020]. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872020000100124
Parry J.Neumonía en China: La falta de información genera preocupación entre los trabajadores sanitarios de Hong Kong. [Internet] BMJ 2020. [Consultado 11 de octubre 2020] Disponible en: https://www.bmj.com/content/368/bmj.m56?__cf_chl_jschl_tk__=81126c26856240e685b9160151d609407b16290b- 1602710710-0-ATN6aCjCxgYi-sdJs1ty1NkF5Nsjp9TTPjLFrp5fFWrZgwqC1Vk_1GWLltcXJB24phVO1st1hNfnCnKuuch2eNshoPm1cTFTzjg2Gp41iTJxc_N_6 pdpmZAQZhYdwpoJF09yti6afgBxajQrA6SAZdwRGiie3aqkXuWxjFs2UDCXdLEvlHEhHtXCTcdkLnVppDGPxg_get-ARXJZrXVXYYbDwwPQOmecGZ2zk8texR9oFl14AvBD0Y6MFwui1Vbq64HhL2-tb-p4HgEw3auogJlyPW71R1FtBnjews0LWlYT 10. Bogoch II., Watts A., Thomas-Bachli A., Huber C., Kraemer MUG., Khan K. Pneumonia of Unknown Etiology in Wuhan, China: Potential for International Spread Via Commercial Air Travel [Internet]. J Travel Med. 2020; [Consultado 11 de octubre 2020] Disponible en: https://academic.oup.com/jtm/article/27/2/taaa008/5704418
Usi E. Ciudad de México: ¿estrategia ejemplar en el manejo del coronavirus? [Internet]. AMÉRICA LATINA. Made for minds. [Consultado 22 de octubre del 2020]. Disponible en: https://www.dw.com/es/ciudad-de-m%C3%A9xico- estrategia-ejemplar-en-el-manejo-del-coronavirus/a-55008269
WHO. Coronavirus disease 2019 (COVID-19). Situation Report-121. 2020 consultado el 22 de octubre de 2020. https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200520-covid-19-sitrep-121.pdf? sfvrsn=c4be2ec6_2.
Barney S.Rapid COVID-19 vaccine development[Internet] Science 29 May 2020[ consultado el 22 de agosto de 2020] Disponible en: DOI10.1126/science.abb8923
González M. “Tendremos vacuna mexicana contra el COVID-19”: los detalles del esfuerzo científico para encontrar la llave contra la pandemia [Internet]. México. Infobae. Agosto de 2020 [Consultado 22 de octubre del 2020]. Disponible en: https://www.infobae.com/america/mexico/2020/08/25/tendremos-vacuna-mexicana-contra-el-covid- 19-los-detalles-del-esfuerzo-cientifico-para-encontrar-la-llave-contra-la-pandemia/
Sereno A. El movimiento antivacunas existe en México y se está expandiendo [Internet]. LOS INTANGIBLES. 2019 [Consultado 22 de octubre del 2020]. Disponible en: https://losintangibles.org/2019/01/31/movimiento-antivacunas- existe-en-mexico/
YouTube. Cuestionamiento y la mediación 1 y 2. Disponible en: https://youtu.be/kiEzIBlL-R4 https://youtu.be/24ChgjagHkM
Hernández, M, Hernández C, López A, Barragán N, Islas I, Ruvalcaba J, et al.Values-attributes Needed to Make Decisions in Health, from the Essential Functions of Public Health. American Journal of Public HealthResearch. [Internet] vol. 5 (5): 154-158. Disponible en: http://article.scipublichealthresearch.com/pdf/ajphr-5-5-3.pdf
Cruz-Olvera J. Valores. Atributos necesarios para tomar decisiones en salud, a partir de las funciones esenciales de la salud pública. [Internet] Educación y Salud Boletín Científico de Ciencias de la Salud del ICSa. 2018; 7(13): 13-15 [Consultado 05 octubre 2020]. Disponible en: https://repository.uaeh.edu.mx/revistas/index.php/ICSA/article/view/3453/4658 19. Medicina Digital. Mexicanos reconocen a la prevención de enfermedades graves y hasta letales [Internet]. México. 07 mayo 2020. [Consultado 05 octubre 2020]. Disponible en: https://www.medicinadigital.com/index.php/ciencia/investigacion/item/37755- mexicanos-reconocen-a-la-prevencion-de-enfermedades-graves-y-hasta-letales
Jackson, L, Anderson, E, Nadine, M, Roberts, P, et al. An mRNA Vaccine against SARS-CoV-2-Preliminary Report. NEJM. Julio 14, 2020 [Consultado 22 octubre 2020] DOI: 10.1056/NEJMoa2022483. Disponible en: https://www.nejm.org/doi/10.1056/NEJMoa2022483
León-Lara X, Otero-Mendoza F. Desarrollo de vacunas contra SARS-CoV-2. Acta Pediatr Méx 2020; 41 (Supl 1):S23- S26.
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
